niacinamide has been researched along with piroxicam in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Balasubramaniam, J; Kumar, MT; Pandit, JK; Verma, MM | 1 |
| Figler, H; Figler, R; Gewirtz, A; Kolachala, V; Linden, J; Merlin, D; Mwangi, S; Ruble, B; Sitaraman, S; Srinivasan, S; Vijay-Kumar, M; Wang, L | 1 |
| Hirakura, Y; Terada, K; Teramura, T; Yamashita, H; Yuda, M | 1 |
| Ahmad, L; Akhlaq Mughal, M; Hassan, M; Iqbal, Z; Khan, A; Khan, I; Nasir, F; Raza, A | 1 |
| Nagy, S; Pál, S; Salem, A; Széchenyi, A | 1 |
1 trial(s) available for niacinamide and piroxicam
| Article | Year |
|---|---|
Dissolution, bioavailability and ulcerogenic studies on piroxicam-nicotinamide solid dispersion formulations.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Calorimetry, Differential Scanning; Capsules; Humans; Niacinamide; Piroxicam; Rats; Solubility; Stomach Ulcer; Tablets; X-Ray Diffraction | 2003 |
6 other study(ies) available for niacinamide and piroxicam
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Blockade of adenosine A2B receptors ameliorates murine colitis.
Topics: Adenosine A2 Receptor Antagonists; Animals; Anti-Inflammatory Agents; Apoptosis; Binding, Competitive; Cell Line; Cell Proliferation; Colitis; Colon; Cyclic AMP; Cytokines; Dextran Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Gastrointestinal Agents; Humans; Inflammation Mediators; Interleukin-10; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Knockout; Niacinamide; Piroxicam; Receptor, Adenosine A2B; Transfection | 2008 |
Detection of cocrystal formation based on binary phase diagrams using thermal analysis.
Topics: Caffeine; Calorimetry, Differential Scanning; Camphor; Carbamazepine; Crystallization; Heating; Indomethacin; Niacinamide; Pharmaceutical Preparations; Phase Transition; Piroxicam; Powder Diffraction; Salicylic Acid; Theophylline; X-Ray Diffraction | 2013 |
A simple, rapid and sensitive RP-HPLC-UV method for the simultaneous determination of sorafenib & paclitaxel in plasma and pharmaceutical dosage forms: Application to pharmacokinetic study.
Topics: Animals; Calibration; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Dosage Forms; Niacinamide; Paclitaxel; Phenylurea Compounds; Piroxicam; Rabbits; Reproducibility of Results; Sorafenib; Ultraviolet Rays | 2016 |
Reliability of the Hansen solubility parameters as co-crystal formation prediction tool.
Topics: Caffeine; Carbamazepine; Chemistry, Pharmaceutical; Crystallization; Niacinamide; Piroxicam; Solubility; Theophylline | 2019 |